KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 158 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $10,872,000 | +6.0% | 702,351 | 0.0% | 3.89% | -10.5% |
Q3 2020 | $10,254,000 | -17.0% | 702,351 | +7.7% | 4.34% | -21.2% |
Q2 2020 | $12,356,000 | +14.4% | 652,351 | +16.0% | 5.51% | -15.9% |
Q1 2020 | $10,803,000 | +40.3% | 562,351 | +40.0% | 6.55% | +40.4% |
Q4 2019 | $7,699,000 | – | 401,609 | – | 4.67% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |